[March 18, 2014] |
 |
Research and Markets: The Global Antibody Drug Conjugate Market Outlook 2018 is Anticipated to Reach US$ 3.45 Billion By 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/7h4p7l/global_antibody)
has announced the addition of the "Global
Antibody Drug Conjugate Market Outlook 2018" report to their
offering.
The ADC (News - Alert) technology is not new. It dates back to the 90s. However,
several issues such as specificity of the payload (drug), and poor
conjugation of drug and antibody proved a setback. But, the past few
years have witnessed ADCs make a glorious comeback. This can be
attributed to the significant advancements that have been made in the
field of linker technology as well as payload efficacy and specificity.
There are currently two ADC products in the market, Adcetris and Kadcla.
According to the report, Global Antibody Drug Conjugate Market Outlook
2018, backed by improved understanding and better technology, the ADC
market is anticipated to reach US$ 3.45 Billion by 2018. The report
analyzes the market for Adcetris and Kadcyla in detail. Market potential
for these drugs has been estimated keeping in mind the fact that these
drugs are being tested in clinical trials for various indications apart
from the ones for which they are approved. These drugs will take some
time in order to capture their entire potential market.
The report also provides an insight into the key ADCs that are currently
in pipeline. At present, only one drug, Inotuzumab Ozogamicin is in late
stage clinical trial. Apart from new drug candidates, previously
approved drugs are also in late stage trials for other indications.
Later in the report, strategic activities such as mergers, acquisitions
and collaborations that have taken place over ADC have been provided.
These activities are aimed at combining technologies and capabilities of
other companies with inherent ones for the development of ADCs.
Companies Mentioned:
-Celldex Therapeutics
-Progenics
-Roche
-Sanofi
-Seattle Genetics
For more information visit http://www.researchandmarkets.com/research/7h4p7l/global_antibody
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]
|